Veterinary Oversight of Antimicrobial Use in Animals in Canada
Veterinary oversight of antimicrobial use is being strengthened in Canada as part of the fight against antimicrobial resistance. This means important changes for you as a practitioner and for the veterinary profession.
Health Canada is moving a number of Medically Important Antimicrobials (MIAs) approved for veterinary use before 2004 to the Prescription Drug List (PDL). With this change, Health Canada will establish the same level of oversight for those MIAs approved before 2004 as for those approved after.
As of December 1, 2018, all MIAs for veterinary use will be on the PDL and must be sold by prescription only. Read more here.
Who we are working with
The Canadian Veterinary Medical Association (CVMA), along with other stakeholders, have been engaging with the Veterinary Drug Directorate about these changes and will continue to support these actions with ongoing engagement and communication.
Throughout 2016, CVMA in partnership with the Canadian Council of Veterinary Registrars (CCVR), provided key relevant information to help increase awareness of key issues and new developments as the new regulations are finalized and implemented. Find more information here.
After broad stakeholder consultation and discussion, the CCVR and the CVMA’s Veterinary Pharmaceutical Stewardship Advisory Group developed a pan-Canadian framework of professional standards for veterinarians regarding veterinary oversight of antimicrobial use. It is available for download here.